| 1 |
34188177 | Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. | 2022 Apr |
1 |
| 2 |
34149863 | Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking. | 2021 |
1 |
| 3 |
31884961 | Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. | 2019 Dec 30 |
2 |
| 4 |
26958937 | Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. | 2016 Mar 29 |
5 |
| 5 |
25902914 | Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. | 2015 Apr 23 |
12 |
| 6 |
23470866 | Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. | 2013 May 23 |
1 |
| 7 |
23612020 | Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. | 2013 Jul |
10 |
| 8 |
22607196 | Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. | 2012 Aug |
1 |
| 9 |
19585117 | Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. | 2010 Feb |
1 |
| 10 |
19626645 | Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. | 2009 Dec |
12 |